Insider Trading March 31, 2026

QNB Corp Director Adds $9,999 Position as Shares Hover Near 52-Week Peak

Small purchase increases direct holdings; dividend streak and yield noted in regulatory filing

By Hana Yamamoto QNBC
QNB Corp Director Adds $9,999 Position as Shares Hover Near 52-Week Peak
QNBC

Director Randy S. Bimes purchased 262.9503 shares of QNB Corp (QNBC) on March 27, 2026, at $38.03 per share for a total of $9,999. The trade, reported on a Form 4 filed March 31, 2026, raises his direct stake to 266,299.2831 shares, which includes 981.8146 shares acquired through the company's Dividend Reinvestment Plan. QNB Corp is listed as having paid dividends for 30 consecutive years with a current yield of 3.95%. The transaction occurred while the stock was trading near its 52-week high.

Key Points

  • Director Randy S. Bimes acquired 262.9503 shares of QNB Corp on March 27, 2026, for $9,999 at $38.03 per share.
  • After the purchase, direct ownership stands at 266,299.2831 shares, which incorporates 981.8146 shares from the Dividend Reinvestment Plan.
  • The transaction was reported on a Form 4 filed with the SEC on March 31, 2026; the filing was signed by David W Freeman as Power of Attorney. Markets impacted: equities and dividend-focused investors.

Director Randy S. Bimes purchased a small block of QNB Corp common stock on March 27, 2026, according to a Form 4 filed with the Securities and Exchange Commission. The filing records an acquisition of 262.9503 shares at $38.03 apiece, bringing the transaction value to $9,999.

This purchase was executed while the company's shares were trading near their 52-week high of $39.99; the report lists the current share price at $40. Following the acquisition, Bimes now directly owns 266,299.2831 shares of QNB Corp. The reported total includes 981.8146 shares that were obtained through the Dividend Reinvestment Plan (DRIP).

The Form 4 documenting the transaction was submitted to the SEC on March 31, 2026. The filing bears the signature of David W Freeman acting as Power of Attorney.

InvestingPro data referenced in the filing notes that QNB Corp has paid dividends for 30 consecutive years and carries a current dividend yield of 3.95%.


Context and holdings

While the purchase amount is modest at $9,999, the filing updates Mr. Bimes' directly held position to 266,299.2831 shares, reflecting both the newly acquired shares and the DRIP component. The transaction came as the stock was trading close to its year-to-date high, with the 52-week ceiling listed at $39.99 and the most recently reported quote at $40.

Reporting details

The transaction was disclosed via a Form 4 filed on March 31, 2026, and the submission was signed by David W Freeman as Power of Attorney. The filing provides the official regulatory record for the director's purchase.


What is known from the filing

  • Buyer: Director Randy S. Bimes
  • Shares purchased: 262.9503
  • Price per share: $38.03
  • Total transaction value: $9,999
  • Post-transaction direct ownership: 266,299.2831 shares (including 981.8146 DRIP shares)
  • Dividend record: 30 consecutive years of payments; current yield 3.95%
  • Form 4 filing date: March 31, 2026; signed by David W Freeman as Power of Attorney

The filing provides a concise, verifiable record of the insider purchase and related ownership totals. Beyond those items recorded in the SEC filing and the InvestingPro dividend figures, the filing does not include further commentary on strategy, intent, or future plans tied to the holding.

Risks

  • The purchase amount was modest ($9,999), which may limit the signal one can draw from the transaction.
  • The acquisition occurred while the stock was trading near its 52-week high ($39.99), a price context that can introduce valuation risk for buyers.
  • There is a short reporting interval between the trade date (March 27, 2026) and the Form 4 filing (March 31, 2026); the filing itself does not provide additional information about intent or future transactions.

More from Insider Trading

Herzfeld Credit Chairman Adds 2,974 Shares as Fund Readies Reverse Split Mar 31, 2026 Cytokinetics Executive Sells Shares as Street Raises Forecasts Mar 31, 2026 Assembly Biosciences CMO Executes Small Sale to Cover Tax Withholding, Receives Large RSU Grant Mar 31, 2026 Assembly Biosciences Executive Sells 328 Shares to Satisfy RSU Tax Withholding Mar 31, 2026 First Mid Bancshares Executive Disposes of $18,778 in Stock as Company Finalizes Two Rivers Deal Mar 31, 2026